Search Results

1 - 10 of 272
Staff
Sangeetha Raghavan is a Senior Licensing and Patenting Manager in NHGRI's Technology Transfer Office.
… in wide ranging areas of biologics, diagnostics, drug delivery, therapeutics, medical devices, plant varieties, … Patented Technology, Licensing, biologics, diagnostics, drug delivery, therapeutics, medical devices, plant …
Archive
… New Paradigm Will Help Identify Leads for Drug Discovery … Archive …
News Release
SJS/TEN is a severe drug reactions that affect the skin, and one of the most severe of adverse reactions affecting any system in the body
… Necrolysis (SJS/TEN). SJS/TEN is the severest of adverse drug reactions that affect the skin, and one of the most … organized a workshop , in collaboration with the Food and Drug Administration (FDA) and other NIH institutes, to … factors that predispose patients to severe immune mediated drug reactions like SJS/TEN, as well as studying the …
News Release
Researchers are asking if the precision medicine approach will reduce or eliminate the role that race plays in prescribing drugs and in health care overall.
… the complex interplay of ancestry, health, disease and drug response. … In a May 26 New England Journal of Medicine … prescribing drugs and in health care overall. "We focus on drug therapies because that's where the precision medicine … imprecise prescribing practices. This means including in drug studies people from diverse social, racial and ethnic, …
News Release
NIH researchers have identified a treatment that significantly decreases the risk of stroke in children with a rare genetic disease called Deficiency of Adenosine Deaminase Type 2 (DADA2).
… reason. … Benefits of the Treatment … Anti-inflammatory drug halts strokes in children with rare disease … NIH …
Archive
… NHGRI Researchers Create New Database of Drug-Metabolizing Enzymes … Archive …
Archive
… Gene-disease association data could improve drug development … Archive …
Archive
… 2001: FDA Approves Genetics-based Drug to Treat Leukemia … Archive …